Effects of Different Crosslinkers on the Release Profiles of Growth Factors (TGF-ß, BMP and PDGF) From Hydroxyapatite Combined With Secretomes

Yunita  Purnamasari; Ferdiansyah Mahyudin; Mouli  Edward

doi:10.5937/scriptamed57-60517

Yunita Purnamasari 1) Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia 2) Department of Orthopaedics and Traumatology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia https://orcid.org/0009-0009-6610-7875
Ferdiansyah Mahyudin Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Airlangga/ Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Mouli Edward 1) Department of Orthopaedics and Traumatology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia 2) Department of Orthopaedics and Traumatology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia https://orcid.org/0000-0002-1667-9770

DOI: https://doi.org/10.5937/scriptamed57-60517

Keywords: Durapatite, Secretome, Crosslinker, Sustained release, Intercellular signalling peptides and proteins, Bone regeneration

Abstract

Background/Aim: Controlled release of growth factors is essential for bone regeneration, requiring biomaterials with high stability and osteoconductivity. Hydroxyapatite (HA) is biocompatible and osteoconductive but limited by weak mechanical strength and uncontrolled growth factor release. This study evaluated the release profiles of transforming growth factor-beta (TGF-β), bone morphogenetic protein (BMP) and platelet-derived growth factor (PDGF) from HA combined with secretome and crosslinked using polyvinyl alcohol (PVA), glutaraldehyde (GA), or aluminium hydroxide gel (Alhydrogel), aiming to identify the most effective crosslinker for controlled release and scaffold stability.

Methods: In vitro tests were conducted on four groups (n = 6 each): HA + PVA 0.5 % + Secretome, HA + GA 0.1 % + Secretome, HA + Alhydrogel 0.1 % + Secretome and a non-crosslinked control. HA derived from bovine bone was sterilised using gamma radiation, then crosslinked through immersion and dry-heat treatment. Samples were incubated in PBS at 37 °C and growth factor release was analysed using ELISA on days 1, 3, 7, 10 and 14.

Results: HA + PVA showed the highest TGF-β release (617.90 ± 18.66 ng/L) and the most stable BMP (0.19 ng/L) and PDGF (0.61 ng/L) profiles. HA + Alhydrogel had the highest BMP release (6.01 ± 0.50 ng/L) and stable TGF-β (7.57 ng/L), while HA + GA had the highest PDGF release (27.27 ± 1.92 ng/L). The control showed rapid but unstable release.

Conclusion: HA combined with secretome and PVA offers the most stable and sustained release, supporting its use as an optimal scaffold for bone regeneration.

References

Kattimani VS, Kondaka S, Lingamaneni KP. Hydroxyapatite–past, present, and future in bone regeneration. Bone Tissue Regen Insights. 2016;7: BTRI.S36138. doi: 10.4137/BTRI.S36138.

Mahyudin F, Utomo DN, Suroto H, Martanto TW, Edward M, Gaol IL. Comparative effectiveness of bone grafting using xenograft freeze-dried cortical bovine, allograft freeze-dried cortical New Zealand white rabbit, xenograft hydroxyapatite bovine, and xenograft demineralized bone matrix bovine in bone defect of femoral diaphysis of white rabbit: experimental study in vivo. Int J Biomater. 2017;2017:7571523. doi: 10.1155/2017/7571523.

Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov. 2008;92:161-8. doi: 10.1007/s12306-008-0064-1.

Yun YR, Jang JH, Jeon E, Kang W, Lee S, Won JE, et al. Administration of growth factors for bone regeneration. Regen Med. 2012 May;7(3):369-85. doi: 10.2217/rme.12.1.

Chen L, Xu Y, Zhao J, Zhang Z, Yang R, Xie J, et al. Conditioned medium from hypoxic bone marrow-derived mesenchymal stem cells enhances wound healing in mice. PLoS One. 2014;9:e96161. doi: 10.1371/journal.pone.0096161.

Daemi H, Rajabi-Zeleti S, Sardon H, Barikani M, Khademhosseini A, Baharvand H. A robust super tough biodegradable elastomer engineered by supramolecular ionic interactions. Biomaterials. 2016;84:54-63. doi: 10.1016/j.biomaterials.2016.01.025.

Daemi H, Barikani M. Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles. Scientia Iranica. 2012;19:2023-8. doi: 10.1016/j.scient.2012.10.005.

Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18:1852. doi: 10.3390/ijms18091852.

Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel JC, et al. Paracrine mechanisms of mesenchymal stromal cells in angiogenesis. Stem Cells Int. 2020;2020:4356359. doi: 10.1155/2020/4356359.

Hsiao ST, Asgari A, Lokmic Z, Sinclair R, Dusting GJ, Lim SY, et al. Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue. Stem Cells Dev. 2012;21:2189-203. doi: 10.1089/scd.2011.0674.

Kim JM, Lin C, Stavre Z, Greenblatt MB, Shim JH. Osteoblast-Osteoclast Communication and Bone Homeostasis. Cells. 2020 Sep 10;9(9):2073. doi: 10.3390/cells9092073.

Abidharma IPS. [Comparative test of the effect of crosslinker on changes in biomechanical strength & toxicity in crosslinked hydroxyapatite] [thesis]. Surabaya: Universitas Airlangga; 2023. Indonesian.

Zhao HY, Wu J, Zhu JJ, Xiao ZC, He CC, Shi HX, et al. Research advances in tissue engineering materials for sustained release of growth factors. Biomed Res Int. 2015;2015:808202. doi: 10.1155/2015/808202.

Tsurushima H, Marushima A, Suzuki K, Oyane A, Sogo Y, Nakamura K, et al. Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor 2. Acta Biomater. 2010;6:2751-9. doi: 10.1016/j.actbio.2009.12.045.

Foo JB, Looi QH, Chong PP, Hassan NH, Yeo GEC, Ng CY, et al. Comparing the therapeutic potential of stem cells and their secretory products in regenerative medicine. Stem Cells Int. 2021 Aug 19;2021:2616807. doi: 10.1155/2021/2616807.

Gugliandolo A, Fonticoli L, Trubiani O, Rajan TS, Marconi GD, Bramanti P, et al. Oral bone tissue regeneration: mesenchymal stem cells, secretome, and biomaterials. Int J Mol Sci. 2021 May 15;22(10):5236. doi: 10.3390/ijms22105236.

Ball JR, Shelby T, Hernandez F, Mayfield CK, Lieberman JR. Delivery of growth factors to enhance bone repair. Bioengineering (Basel). 2023 Oct 26;10(11):1252. doi: 10.3390/bioengineering10111252.

Hao ZW, Zhang ZY, Wang ZP, Wang Y, Chen JY, Chen TH, et al. Bioactive peptides and proteins for tissue repair: microenvironment modulation, rational delivery, and clinical potential. Mil Med Res. 2024 Dec 5;11(1):75. doi: 10.1186/s40779-024-00576-x..

Edward M, Suyono RE, Warindra T. Effect of bovine hydroxyapatite composite with secretome under normoxia and hypoxia conditions on inflammatory parameters in massive bone defect of rabbit radius bone. J Biomater Appl. 2024 Nov;39(5):466-2. doi: 10.1177/08853282241272998.

Saberian E, Jenča A, Zafari Y, Jenča A, Petrášová A, Zare-Zardini H, et al. Scaffold application for bone regeneration with stem cells in dentistry: literature review. Cells. 2024 Jun 19;13(12):1065. doi: 10.3390/cells13121065.